Cadrenal Therapeutics, Inc. Common Stock
Cadrenal Therapeutics, Inc. Common Stock（CVKD）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · CVKD · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
32
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Cadrenal Therapeutics, Inc. Common Stock内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
CVKD 季度内部人买卖趋势
CVKD 内幕交易卖出 · CVKD 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · CVKD CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
CVKD 高管卖出股份 · CVKD 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 3, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,323 | $10K | Form 4 |
| Jun 4, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 3,898 | $17K | Form 4 |
| Jun 5, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,064 | $9K | Form 4 |
| May 29, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 303 | $2K | Form 4 |
| Jun 2, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 349 | $2K | Form 4 |
| May 11, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 6,476 | $37K | Form 4 |
| May 12, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 3,298 | $17K | Form 4 |
| May 28, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 2,989 | $15K | Form 4 |
| May 22, 2026 | Pham Quang X CEO and Chairman · Director | Sale | 1,165 | $7K | Form 4 |
| Dec 29, 2025 | Szot Matthew K CFO | Sale | 9,933 | $69K | Form 4 |
| Oct 24, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 27, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 24, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,129 | $16K | Form 4 |
| Oct 27, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,315 | $18K | Form 4 |
| Oct 9, 2025 | Szot Matthew K CFO | Sale | 1,693 | $24K | Form 4 |
| Oct 13, 2025 | Szot Matthew K CFO | Sale | 1,800 | $25K | Form 4 |
| Oct 9, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,800 | $25K | Form 4 |
| Oct 13, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 1,800 | $25K | Form 4 |
| Oct 6, 2025 | Szot Matthew K CFO | Sale | 107 | $1K | Form 4 |
| Oct 2, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 500 | $7K | Form 4 |
| Sep 29, 2025 | Szot Matthew K CFO | Sale | 100 | $1K | Form 4 |
| Oct 1, 2025 | Szot Matthew K CFO | Sale | 1,700 | $24K | Form 4 |
| Sep 29, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 419 | $6K | Form 4 |
| Oct 1, 2025 | Pham Quang X CEO and Chairman · Director | Sale | 881 | $12K | Form 4 |
| Sep 24, 2025 | Szot Matthew K CFO | Sale | 1,500 | $21K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 CVKD 内幕交易
CVKD 内幕交易
Cadrenal Therapeutics, Inc. Common Stock（CVKD）内幕交易数据来源于公司内部人（包括Pham Quang X (CEO and Chairman · Director), Szot Matthew K (CFO)）提交的SEC Form 4申报文件。过去12个月内，2位内部人向SEC提交了交易申报。CVKD内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Cadrenal Therapeutics, Inc. Common Stock机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
CVKD 内幕交易 · 5个问题Cadrenal Therapeutics, Inc. Common Stock（CVKD）的内部人包括高管和董事，如Pham Quang X (CEO and Chairman · Director), Szot Matthew K (CFO)等。过去12个月内，2位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026